This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Obstructive Pulmonary Disease (COPD)
and you are
over 40
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The objective is to provide data supporting the use of LAS40464 as an efficacious and safe maintenance bronchodilator treatment of patients with Chronic Obstructive Pulmonary Disease (COPD).

Provided treatments

  • Drug: Aclidinium Bromide/Formoterol Fumarate
  • Drug: Aclidinium Bromide/Formoterol Fumarate
  • Drug: Aclidinium Bromide
  • Drug: Placebo
  • Drug: Formoterol Fumarate

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01462942. The sponsor of the trial is AstraZeneca and it is looking for 2443 volunteers for the current phase.
Official trial title:
Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-dose Combinations Compared With Individual Components and Placebo When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease.